Top compounds associated with response to RP13-582O9.6


Feature Type Standardized
Nominal ANOVA
mRNA ML162 CTRPv2 pan-cancer AAC 0.058 0.08
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.09
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC 0.063 0.09
mRNA prima-1 CTRPv2 pan-cancer AAC 0.053 0.09
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.17 0.09
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.058 0.09
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.057 0.09
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.052 0.09
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.063 0.09
Download CSV